LAVORINI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.767
EU - Europa 6.843
AS - Asia 1.179
AF - Africa 50
OC - Oceania 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.845
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.738
PL - Polonia 2.931
RU - Federazione Russa 1.836
IT - Italia 612
IE - Irlanda 601
SG - Singapore 389
SE - Svezia 323
CN - Cina 266
HK - Hong Kong 228
FI - Finlandia 111
DE - Germania 108
UA - Ucraina 102
VN - Vietnam 99
IN - India 90
GB - Regno Unito 77
JO - Giordania 75
CH - Svizzera 44
CI - Costa d'Avorio 41
NL - Olanda 30
CA - Canada 26
ES - Italia 23
FR - Francia 23
TR - Turchia 15
BE - Belgio 12
RO - Romania 6
SC - Seychelles 6
KR - Corea 5
JP - Giappone 3
MY - Malesia 3
BR - Brasile 2
ID - Indonesia 2
MU - Mauritius 2
MX - Messico 2
NZ - Nuova Zelanda 2
AU - Australia 1
CR - Costa Rica 1
EU - Europa 1
IR - Iran 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MM - Myanmar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 16.845
Salva come PNG Salva come JPEG
Città #
Warsaw 2.930
Santa Clara 2.517
Fairfield 1.031
Dublin 594
Ashburn 513
Woodbridge 444
Chandler 412
Seattle 408
Cambridge 389
Houston 368
Wilmington 334
Singapore 302
Altamura 178
Ann Arbor 177
Lawrence 170
Princeton 162
Jacksonville 143
Moscow 115
Boston 112
Florence 97
Hong Kong 97
Dong Ket 90
Beijing 83
Mumbai 82
San Diego 78
Milan 63
Medford 62
Boardman 58
Buffalo 58
Shanghai 58
Bern 44
Abidjan 41
Falls Church 37
Norwalk 36
Kent 30
Phoenix 24
Barcelona 22
Helsinki 22
New York 22
London 21
Yubileyny 21
Washington 20
Hillsboro 18
Toronto 17
Los Angeles 16
Lappeenranta 15
Munich 14
Amsterdam 13
Izmir 13
Brussels 12
Guangzhou 12
West Jordan 12
Andover 10
Frankfurt am Main 10
Nanjing 10
Redwood City 8
Bari 7
Messina 7
Rome 7
Beauharnois 6
Shenzhen 6
Modena 5
Pune 5
Romola 5
Salerno 5
Seoul 5
Auburn Hills 4
Cagliari 4
Chicago 4
Dearborn 4
Incisa 4
Laurel 4
Reggio Calabria 4
San Mateo 4
Scandicci 4
Campobasso 3
Falkenstein 3
Forest City 3
Hefei 3
Livorno 3
Lizzano in Belvedere 3
Porcia 3
Redmond 3
Reggio Emilia 3
Serrazzano 3
St Petersburg 3
Treviso 3
Wuxi 3
Zhengzhou 3
Arnsberg 2
Cassola 2
Due Carrare 2
Düsseldorf 2
Ferrara 2
Fisciano 2
Foggia 2
Frankfurt Am Main 2
Fucecchio 2
Fuzhou 2
Garden City 2
Totale 12.803
Salva come PNG Salva come JPEG
Nome #
Antitussive effect of carcainium chloride in patients with chronic cough and idiopathic interstitial pneumonias: A pilot study 296
Effect of an anti-reflux medical device in the control of deflation cough: A placebo-controlled comparative study with an antacid drug in chronic coughers 245
A Randomized Clinical Trial Comparing the Effects of Antitussive Agents on Respiratory Center Output in Patients With Chronic Cough. 241
Pulmonary hypertension nosography: are all patients classifiable? 241
Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD 240
Cough and ventilatory adjustments evoked by aerosolised capsaicin and distilled water (fog) in man 228
Diagnosis and treatment of pulmonary embolism: a multidisciplinary approach. 225
Gorham-Stout Disease Management during Pregnancy 225
Inhaler technique: Facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT) 222
A 57-year-old chronic cougher with somatically evoked cough. 212
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD 209
Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to Therapy 204
Recent advances in capsule-based dry powder inhaler technology 196
The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis 195
Increased Risk of Atherosclerosis in Patients with Sarcoidosis 188
Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here? 175
Critical inhaler errors in asthma and COPD: A systematic review of impact on health outcomes 174
Concomitant Bilastine and Montelukast as Additive Therapy for Seasonal Allergic Rhinoconjunctivits and Mild-to-Moderate Asthma. The SKY Study 168
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes 168
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting 161
Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: The Easy Low Instruction Over Time (ELIOT) study 156
Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease 151
Desensitization of the cough reflex by exercise and voluntary isocapnic hyperpnea 149
Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR) 147
The lung microbiome: clinical and therapeutic implications 146
Pulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPD. 145
A multinational observational study identifying primary care patients at risk of overestimation of asthma control 144
Fog-induced Cough With Impaired Respiratory Sensation in Congenital Central Hypoventilation Syndrome. 140
100 Years of Drug Delivery to the Lungs 140
Inhaler technique mastery and maintenance in healthcare professionals trained on different devices 140
A noninvasive electromyographic study on threshold and intensity of cough in humans. 134
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 134
The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes 133
Different respiratory behaviors disclosed by induced bronchoconstriction in mild asthma patients. 133
The ADMIT series – Issues in Inhalation Therapy. 5) Inhaler selection in children with asthma 132
Handgrip-induced airway dilation in asthmatic patients with bronchoconstriction induced by MCh inhalation. 129
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 127
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study 126
The demographic and clinical characteristics of an Italian population of adult outpatients with chronic cough 124
Validation of a method to assess emphysema severity by spirometry in the COPDGene study. 121
Retail sales of inhalation devices in European countries: So much for a global policy 119
EP1.04-02 Predictors of Lung Toxicity in First Line Pembrolizumb for Advanced NSCLC: An Interim Analysis of PRELUTOX Study 118
Desensitization of the cough reflex by exercise and voluntary isocapnic hyperpnea 117
Clinical courses and outcomes of five patients with primary lung cancer surgically treated while affected by Severe acute respiratory syndrome coronavirus 2 117
Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. 116
Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: A retrospective matched observational study of real-world patients 116
Respiratory expulsive efforts evoked by maximal lung emptying. 115
Respiratory rate assessments using a dual-accelerometer device 115
The Clinical Value of Deflation Cough in Chronic Coughers with Reflux Symptoms 113
The challenge of delivering therapeutic aerosols to asthma patients 113
What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape 112
Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes 112
Defective motor control of coughing in Parkinson's disease. 111
Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: A randomised, crossover, open-label study 111
Inhaler technique and patient's preference for dry powder inhaler devices 107
Repeatability of cough-related variables during fog challenges at threshold and suprathreshold stimulus intensity in humans. 106
Coughing in laryngectomized patients. 106
Voluntary and reflex cough: Similarities and differences 106
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab 106
The Fontana paradoxical reflex? 105
Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series 103
Prostaglandin synthesis blockade by ketoprofen attenuates respiratory and cardiovascular responses to static handgrip. 103
Fog-induced respiratory responses are attenuated by nedocromil sodium in humans 102
Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices 101
Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab 101
Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based on functional antagonism. 100
The fi rst tissue-engineered airway transplantation: 5-year follow-up results 100
Large and small airway responses to procaterol hydrochloride administered through different extension devices in asthmatic patients 99
Dilemmas, Confusion, and Misconceptions Related to Small Airways Directed Therapy 98
Correct inhalation technique is critical in achieving good asthma control 98
A crossover randomized comparative study of zofenopril and ramipril on cough reflex and airway inflammation in healthy volunteers 98
Diagnostic strategies for suspected pulmonary embolism 97
Targeting drugs to the airways: the role of spacer devices 97
Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction 96
Breathing pattern during fog challenges in humans 96
The ADMIT series--issues in inhalation therapy. 2. Improving technique and clinical effectiveness 95
Switching treatments in COPD: Implications for costs and treatment adherence 95
What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis 94
Patients’ perspectives and preferences in the choice of inhalers: The case for Respimat® or HandiHaler® 93
Serum sodium alterations in SARS CoV-2 (COVID-19) infection: Impact on patient outcome 92
The ADMIT series - Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD. 91
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 91
Agreement between two methods fr assessing bioequivalence of inhaled salbutamol. 90
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 89
Cough in children with congenital central hypoventilation syndrome. 88
Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: a retrospective validation study 88
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 88
Prevalence of nutritional risk and malnutrition during and after hospitalization for COVID-19 infection: Preliminary results of a single-centre experience 88
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD 87
ADMIT Working Group. Inhaler choice and inhalation technique: key factors for asthma control. 87
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 87
Classification of COPD patients by using a standardised diagnostic questionnaire 86
Trace metals in fluids lining the respiratory system of patients with idiopathic pulmonary fibrosis and diffuse lung diseases 86
Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center 86
Workshop: Tuning the 'cough center' 84
Clinical implications of interstitial pneumonia with autoimmune features diagnostic criteria in idiopathic pulmonary fibrosis: A case control study 83
New inhaler devices - The good, the bad and the ugly 82
The dry powder inhaler features of the Easyhaler that benefit the management of patients 82
Classification of COPD patients by using standardised diagnostic procedures 81
Determination of ai rway resistance (Raw) and pulmonary flow resistance (RL) during methacoline challenge in children 81
Totale 12.888
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.289
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.044 0 0 0 0 0 253 416 446 341 208 314 66
2020/20212.414 181 276 86 283 119 285 148 211 189 400 76 160
2021/20221.091 51 94 84 32 39 97 37 83 64 62 125 323
2022/20232.380 273 458 76 158 142 407 354 119 220 44 61 68
2023/20241.081 38 131 197 90 90 128 42 149 16 98 62 40
2024/20255.449 251 733 451 1.034 2.236 744 0 0 0 0 0 0
Totale 17.033